Literature DB >> 352946

Heterogeneity of group A streptococcal pyrogenic exotoxin type B.

E L Barsumian, C M Cunningham, P M Schlievert, D W Watson.   

Abstract

Streptococcal pyrogenic exotoxin type B purified from culture filtrates of either the NY-5 or T-19 strain of group A streptococcus was found to be heterogeneous in charge. Three protein fractions with isoelectric points of 8.0, 8.4, and 9.0 were isolated by differential solubility in ethanol and acetate-buffered saline followed by isoelectric focusing and shown to be antigenically identical to streptococcal pyrogenic exotoxin type B. The molecular weights of all three fractions were approximately 17,500, as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, with aggregates forming in the presence of hyaluronic acid. Only the pI 8.4 fraction showed the characteristic activities of streptococcal pyrogenic exotoxin in rabbits: pyrogenicity and ability to enhance susceptibility to lethal endotoxin shock. The pI 8.0 and pI 9.0 fractions were not pyrogenic, but could be used to immunize against pyrogenicity. These two fractions failed either to enhance lethal endotoxin shock or to immunize against enhancement activity. When the isolated fractions were electrofocused again they appeared heterogeneous, suggesting an instability of the B toxin molecular forms.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 352946      PMCID: PMC421884          DOI: 10.1128/iai.20.2.512-518.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Further studies of group A streptococcal factors with lethal and cardiotoxic properties.

Authors:  J H SCHWAB; D W WATSON; W J CROMARTIE
Journal:  J Infect Dis       Date:  1955 Jan-Feb       Impact factor: 5.226

2.  Alteration of clearance function by group A streptococcal pyrogenic exotoxin and its relation to suppression of the antibody response.

Authors:  C M Cunningham; D W Watson
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

3.  Purification and characterization of group A streptococcal pyrogenic exotoxin type C.

Authors:  P M Schlievert; K M Bettin; D W Watson
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

4.  Enhanced immune response after immunosuppression by Streptococcal pyrogenic exotoxin.

Authors:  E E Hanna; D W Watson
Journal:  Infect Immun       Date:  1973-06       Impact factor: 3.441

5.  Purification of exfoliatin produced by Staphylococcus aureus of bacteriophage group 2 and its physicochemical properties.

Authors:  I Kondo; S Sakurai; Y Sarai
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

6.  Microheterogeneity of L-amino acid oxidase. Separation of multiple components by polyacrylamide gel electrofucusing.

Authors:  M B Hayes; D Wellner
Journal:  J Biol Chem       Date:  1969-12-25       Impact factor: 5.157

7.  Evidence for two molecular forms of streptococcal erythrogenic toxin. Conversion to a single form by 2-mercaptoethanol.

Authors:  C Nauciel; J Blass; R Mangalo; M Raynaud
Journal:  Eur J Biochem       Date:  1969-11

8.  Suppression of antibody response by group A streptococcal pyrogenic exotoxin and characterization of the cells involved.

Authors:  C M Cunningham; D W Watson
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

9.  Further purification of group A streptococcal pyrogenic exotoxin and characterization of the purified toxin.

Authors:  C M Cunningham; E L Barsumian; D W Watson
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

10.  Host-parasite factors in group A streptococcal infections. Pyrogenic and other effects of immunologic distinct exotoxins related to scarlet fever toxins.

Authors:  D W WATSON
Journal:  J Exp Med       Date:  1960-02-01       Impact factor: 14.307

View more
  36 in total

1.  Residues 20, 22, and 26 determine the subtype specificities of staphylococcal enterotoxins C1 and C2.

Authors:  T N Turner; C L Smith; G A Bohach
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

2.  Do streptococci cause toxic shock?

Authors:  S Shaunak; A M Gordon
Journal:  BMJ       Date:  1990-12-08

3.  Reinterpretation of the Dick test: role of group A streptococcal pyrogenic exotoxin.

Authors:  P M Schlievert; K M Bettin; D W Watson
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

4.  Streptococcal mitogenic exotoxin Z, a novel acidic superantigenic toxin produced by a T1 strain of Streptococcus pyogenes.

Authors:  Y Kamezawa; T Nakahara; S Nakano; Y Abe; J Nozaki-Renard; T Isono
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

5.  Molecular epidemiologic analysis of the type A streptococcal exotoxin (erythrogenic toxin) gene (speA) in clinical Streptococcus pyogenes strains.

Authors:  C E Yu; J J Ferretti
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

6.  Nucleotide sequence of the staphylococcal enterotoxin C3 gene: sequence comparison of all three type C staphylococcal enterotoxins.

Authors:  C J Hovde; S P Hackett; G A Bohach
Journal:  Mol Gen Genet       Date:  1990-01

7.  Quantification and toxicity of group A streptococcal pyrogenic exotoxins in an animal model of toxic shock syndrome-like illness.

Authors:  P K Lee; P M Schlievert
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

8.  Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C.

Authors:  P M Schlievert
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

9.  Purification and physicochemical and biological characterization of a staphylococcal pyrogenic exotoxin.

Authors:  P M Schlievert; D J Schoettle; D W Watson
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

10.  Characterization of novel type C staphylococcal enterotoxins: biological and evolutionary implications.

Authors:  J C Marr; J D Lyon; J R Roberson; M Lupher; W C Davis; G A Bohach
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.